Blood Thinners for AFib: Help
Protect Yourself Against AFib-related Stroke

Janssen—Your Partner for Cost Support

At Janssen, we don’t want cost to get in the way of treatment you need. We can help you explore options to lower your out-of-pocket cost for XARELTO®.

XARELTO® offers 24-hour stroke-risk reduction in a once-daily pill* *Taken with the evening meal.

See how XARELTO® compares to other blood thinners for nonvalvular atrial fibrillation (AFib)

  NOAC (non-vitamin K antagonist oral anticoagulant) No routine blood monitoring Once-daily dosing No known food restrictions Begins working quickly Has a reversal agent Mean CHA2DS2 -VASc score of patients in clinical study
(Coumadin®, Jantoven®)
Aspirin             N/A

Evaluating different blood thinners for AFib

XARELTO® vs warfarin

XARELTO® and other NOACs (non-vitamin K antagonist oral anticoagulants) are different from older medicines like warfarin (Coumadin®, Jantoven®) because they don’t require blood monitoring, have fewer drug interactions, and pose less risk of major bleeding, particularly in the brain. They also begin working faster and tend to leave the system more quickly, which is beneficial if you plan to have any surgical procedures. Read more about the differences between XARELTO® and warfarin.

My cardiologist said, ‘Look, I've been doing my research—let's take a look at XARELTO®.'

Hear how Paul’s cardiologist helped him find a treatment that worked for him.

Once a day vs twice a day

When it comes to dosing, XARELTO® is the only blood thinner medicine that can be taken once a day, with the evening meal, may make it easier for you to remember your medication. You may feel that taking a twice-daily blood thinner means you are taking less medicine at one time, and therefore have a lower risk for side effects like bleeding. This is not true. The greater concern is that if you happen to miss a dose, your medication is not working as well to
reduce your risk of stroke. With XARELTO®, you have 24-hour stroke risk
reduction with a once-daily pill.

When compared to warfarin, treatment with XARELTO® is associated with lower rates of the types of bleeding that healthcare professionals are most concerned about—this includes life-threatening bleeding and bleeding in the brain.

Balancing stroke risk with bleeding risk

All blood thinners come with a risk of bleeding. However, it’s important to understand that older people with more health issues tend to have both a higher risk of stroke (according to the CHA2DS2-VASc) and a higher risk for bleeding, even before taking a blood thinner.

Before prescribing a blood thinner, your healthcare professional may evaluate treatment options for you based on both your risk for stroke and your risk for bleeding. If you and your healthcare professional choose XARELTO®, it is because the benefit of helping to protect you against the risk of a life-threatening or disabling stroke outweighs your risk of bleeding.

XARELTO® is considered to be effective and safe, even in older people with more health issues, such as kidney disease.

Sign up for ongoing support from Janssen CarePath

Learn about savings options and get help to stay on track with useful information and tools when you register for Janssen CarePath Patient Support for XARELTO®.